Hepatitis C inhibitor peptide analogs
US6908901B2 · kind B2 · utility
41Cited by
6References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2004 |
| Grant date | Jun 21, 2005 |
| Priority date | — |
| Expiry date | Mar 2, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I): wherein B, Y, R3, R24, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.